{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:31:19Z","timestamp":1791563479247,"version":"4.3.4"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council, Canberra, Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cardiology Centre of Excellence from Filippo and Maria Casella","award":["2008129"],"award-info":[{"award-number":["2008129"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Helping people to understand their cardiovascular (CV) risk can influence the choices they make for risk reduction, including medication adherence and lifestyle modification. This study sought whether repeated visualization of coronary artery calcium (CAC) images was effective in sustaining long-term risk control in primary prevention, independent of a risk reduction programme.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>Asymptomatic, statin-na\u00efve participants, 40\u201370 years, with a family history of premature coronary artery disease and a CAC score from 1\u2013400 were randomized to a nurse-led CV risk reduction programme or standard care with bi-annual reviews. Only the intervention group (220 of 449 participants) visualized their CAC image (with repeat exposure in the first 3 months) and were initiated on statin therapy. The primary outcome was change in Framingham Risk Score (FRS) at 36 months, and the impact of CAC image recall on CV risk was assessed. The reduction in FRS (difference in differences (DID) \u22123.4% [95% CI: \u22124.4% to \u22122.4%], P \u2264 0.001 and low density lipoprotein cholesterol \u22121.2\u2005mmol\/L [95% CI: \u22121.4 to \u22121.0], P \u2264 0.001) over 36 months was greater in the intervention than the control group. Within the intervention group, sustained recall of CAC images at 24 months was associated with lower systolic blood pressure (DID \u22124.3\u2005mmHg [95% CI: \u22127.7 to \u22120.9], P = 0.01) and waist circumference (DID \u22122.0\u2005cm [95% CI: \u22123.9 to \u22120.1], P = 0.03) at 36 months compared to unsustained recall.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>A nurse-led programme, combining personalized patient visualization of CAC imaging with statin therapy, is beneficial for improving CV risk. Recalling the presentation of CAC images through repeated visual exposure may influence risk reduction.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Registration<\/jats:title>\n                  <jats:p>Australia New Zealand Clinical Trials Registry: ACTRN12614001294640<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Lay summary<\/jats:title>\n                  <jats:p>This trial sought to determine whether visualization of coronary artery calcium (CAC) images influences behaviour change and cardiovascular risk reduction within a structured nurse-led programme vs. standard care. Intervention participants visualized their personalized CAC images within the first three months and commenced statin therapy. Control participants were blinded to their CAC images and were not provided statin therapy. Intervention participants had a greater absolute reduction in the Framingham Risk Score (difference in differences \u22123.4% [95% CI: \u22124.4% to \u22122.4%], P \u2264 0.001) compared to controls. Those with sustained recollection of their CAC images within the intervention group also had greater reductions in systolic blood pressure and waist circumference.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurjpc\/zwae026","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T04:11:55Z","timestamp":1705551115000},"page":"596-605","source":"Crossref","is-referenced-by-count":13,"title":["Influence of repeated plaque visualization on cardiovascular risk reduction after 3 years: a randomized controlled trial"],"prefix":"10.1093","volume":"32","author":[{"given":"Kristyn","family":"Whitmore","sequence":"first","affiliation":[{"name":"Baker Department of Cardiometabolic Health, The University of Melbourne , Grattan, Parkville, Victoria, 3010 ,","place":["Australia"]},{"name":"Baker Heart and Diabetes Institute , Preclinical Disease and Prevention, 75 Commercial Road, PO Box 6492, Melbourne, Victoria, 3004, Australia"},{"name":"Menzies Institute for Medical Research, University of Tasmania , 17 Liverpool Street , Hobart, Tasmania, 7000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhou","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University , 553 St Kilda Road , Melbourne, Victoria 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline D M","family":"Ryan","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Western Australia, Perth ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costan G","family":"Magnussen","sequence":"additional","affiliation":[{"name":"Baker Heart and Diabetes Institute , Preclinical Disease and Prevention, 75 Commercial Road, PO Box 6492, Melbourne, Victoria, 3004, Australia"},{"name":"Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku , Turku ,","place":["Finland"]},{"name":"Centre for Population Health Research, University of Turku and Turku University Hospital , Turku ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda J","family":"Carrington","sequence":"additional","affiliation":[{"name":"Baker Department of Cardiometabolic Health, The University of Melbourne , Grattan, Parkville, Victoria, 3010 ,","place":["Australia"]},{"name":"Baker Heart and Diabetes Institute , Preclinical Disease and Prevention, 75 Commercial Road, PO Box 6492, Melbourne, Victoria, 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9065-0899","authenticated-orcid":false,"given":"Thomas H","family":"Marwick","sequence":"additional","affiliation":[{"name":"Baker Department of Cardiometabolic Health, The University of Melbourne , Grattan, Parkville, Victoria, 3010 ,","place":["Australia"]},{"name":"Baker Heart and Diabetes Institute , Preclinical Disease and Prevention, 75 Commercial Road, PO Box 6492, Melbourne, Victoria, 3004, Australia"},{"name":"Menzies Institute for Medical Research, University of Tasmania , 17 Liverpool Street , Hobart, Tasmania, 7000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,19]]},"reference":[{"key":"2025051119521147100_zwae026-B1","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/j.jacc.2019.10.009","article-title":"The global burden of cardiovascular diseases and risk factors: 2020 and beyond","volume":"74","author":"Mensah","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2025051119521147100_zwae026-B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-021-10429-0","article-title":"Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017","volume":"21","author":"Amini","year":"2021","journal-title":"BMC Public Health"},{"key":"2025051119521147100_zwae026-B3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/ehjqcco\/qcac014","article-title":"European Society of Cardiology: cardiovascular disease statistics 2021: executive summary","volume":"8","author":"Timmis","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2025051119521147100_zwae026-B4","first-page":"596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"2025051119521147100_zwae026-B5","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1517\/14656560903376186","article-title":"Non-adherence to statin therapy: a major challenge for preventive cardiology","volume":"10","author":"Bates","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"2025051119521147100_zwae026-B6","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1136\/heartjnl-2017-312571","article-title":"Improving medication adherence in patients with cardiovascular disease: a systematic review","volume":"104","author":"Fuller","year":"2018","journal-title":"Heart"},{"key":"2025051119521147100_zwae026-B7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12471-021-01642-y","article-title":"Lifestyle management to prevent atherosclerotic cardiovascular disease: evidence and challenges","volume":"30","author":"van Trier","year":"2022","journal-title":"Neth Heart J"},{"key":"2025051119521147100_zwae026-B8","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"2025051119521147100_zwae026-B9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/JCN.0000000000000103","article-title":"Does knowledge of coronary artery calcium affect cardiovascular risk perception, likelihood of taking action, and health-promoting behavior change?","volume":"30","author":"Johnson","year":"2015","journal-title":"J Cardiovasc Nurs"},{"key":"2025051119521147100_zwae026-B10","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/HYP.0000000000000203","article-title":"Medication adherence and blood pressure control: a scientific statement from the American Heart Association","volume":"79","author":"Choudhry","year":"2022","journal-title":"Hypertension"},{"key":"2025051119521147100_zwae026-B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjopen\/oeac003","article-title":"Time to initiation of lipid-lowering drugs for subclinical atherosclerosis: sub-study of VIPVIZA randomized controlled trial, with single-arm cross-over","volume":"2","author":"Holmberg","year":"2022","journal-title":"Eur Heart J Open"},{"key":"2025051119521147100_zwae026-B12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/cpf.12811","article-title":"Reduced progression of carotid intima media thickness by personalised pictorial presentation of subclinical atherosclerosis in VIPVIZA\u2014a randomised controlled trial","volume":"43","author":"Nyman","year":"2023","journal-title":"Clin Physiol Funct Imaging"},{"key":"2025051119521147100_zwae026-B13","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jcmg.2023.03.007","article-title":"Impact of patient visualization of cardiovascular risk factors","volume":"16","author":"Whitmore","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025051119521147100_zwae026-B14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ahj.2017.09.011","article-title":"Rationale and design of a trial to personalize risk assessment in familial coronary artery disease","volume":"199","author":"Marwick","year":"2018","journal-title":"Am Heart J"},{"key":"2025051119521147100_zwae026-B15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.atherosclerosis.2021.08.002","article-title":"Impact of a coronary artery calcium-guided statin treatment protocol on cardiovascular risk at 12 months: results from a pragmatic, randomised controlled trial","volume":"334","author":"Venkataraman","year":"2021","journal-title":"Atherosclerosis"},{"key":"2025051119521147100_zwae026-B16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/j.1545-7249.2008.tb00127.x","article-title":"Is a picture worth a thousand words?","volume":"42","author":"Rossiter","year":"2008","journal-title":"TESOL Quarterly"},{"key":"2025051119521147100_zwae026-B17","first-page":"84","volume-title":"Guideline for the Diagnosis and Management of Hypertension in Adults","author":"Anderson","year":"2016"},{"key":"2025051119521147100_zwae026-B18","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","article-title":"Medication adherence: its importance in cardiovascular outcomes","volume":"119","author":"Ho","year":"2009","journal-title":"Circulation"},{"key":"2025051119521147100_zwae026-B19","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jcmg.2017.01.030","article-title":"The identification of calcified coronary plaque is associated with initiation and continuation of pharmacological and lifestyle preventive therapies: a systematic review and meta-analysis","volume":"10","author":"Gupta","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025051119521147100_zwae026-B20","doi-asserted-by":"crossref","first-page":"100199","DOI":"10.1016\/j.ajpc.2021.100199","article-title":"The beneficial effect over 3 years by pictorial information to patients and their physician about subclinical atherosclerosis and cardiovascular risk: results from the VIPVIZA randomized clinical trial","volume":"7","author":"Bengtsson","year":"2021","journal-title":"Am J Prev Cardiol"},{"key":"2025051119521147100_zwae026-B21","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.cct.2008.03.001","article-title":"The impact of CAROtid plaque Screening on Smoking (CAROSS) cessation and control of other cardiovascular risk factors: rationale and design of a randomized controlled trial","volume":"29","author":"Rodondi","year":"2008","journal-title":"Contemp Clin Trials"},{"key":"2025051119521147100_zwae026-B22","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.jacc.2011.01.019","article-title":"Impact of coronary artery calcium scanning on coronary risk factors and downstream testing: the EISNER (early identification of subclinical atherosclerosis by noninvasive imaging research) prospective randomized trial","volume":"57","author":"Rozanski","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2025051119521147100_zwae026-B23","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1001\/jama.289.17.2215","article-title":"Impact of electron beam tomography, with or without case management, on motivation, behavioral change, and cardiovascular risk profile: a randomized controlled trial","volume":"289","author":"O\u2019Malley","year":"2003","journal-title":"J Am Med Assoc"},{"key":"2025051119521147100_zwae026-B24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0140-6736(18)32818-6","article-title":"Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial","volume":"393","author":"N\u00e4slund","year":"2019","journal-title":"Lancet"},{"key":"2025051119521147100_zwae026-B25","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.atherosclerosis.2014.07.022","article-title":"The effects of coronary artery calcium screening on behavioral modification, risk perception, and medication adherence among asymptomatic adults: a systematic review","volume":"236","author":"Mamudu","year":"2014","journal-title":"Atherosclerosis"},{"key":"2025051119521147100_zwae026-B26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1520-037X.2006.04862.x","article-title":"Electron beam computed tomography screening and heart disease risk factor modification","volume":"9","author":"Sandwell","year":"2006","journal-title":"Prev Cardiol"},{"key":"2025051119521147100_zwae026-B27","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/S0002-9149(96)00599-1","article-title":"Does coronary artery screening by electron beam computed tomography motivate potentially beneficial lifestyle behaviors?","volume":"78","author":"Wong","year":"1996","journal-title":"Am J Cardiol"},{"key":"2025051119521147100_zwae026-B28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/eurjcn\/zvab042","article-title":"Nurse co-ordinated health and lifestyle modification for reducing multiple cardio-metabolic risk factors in regional adults: outcomes from the MODERN randomized controlled trial","volume":"21","author":"Carrington","year":"2022","journal-title":"Eur J Cardiovasc Nurs"},{"key":"2025051119521147100_zwae026-B29","doi-asserted-by":"publisher","first-page":"S0190-9622(21)00245-0","DOI":"10.1016\/j.jaad.2021.01.085","article-title":"The Hawthorne effect","author":"Elston","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"2025051119521147100_zwae026-B30","doi-asserted-by":"publisher","first-page":"e0201196","DOI":"10.1371\/journal.pone.0201196","article-title":"Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease","volume":"14","author":"Hope","year":"2019","journal-title":"PLoS One"},{"key":"2025051119521147100_zwae026-B31","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/jamacardio.2019.3066","article-title":"Effectiveness of interventions aimed at increasing statin-prescribing rates in primary cardiovascular disease prevention: a systematic review of randomized clinical trials","volume":"4","author":"Sparrow","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2025051119521147100_zwae026-B32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(18)33079-4","article-title":"Confronting the most challenging risk factor: non-adherence","volume":"393","author":"Kones","year":"2019","journal-title":"Lancet"},{"key":"2025051119521147100_zwae026-B33","doi-asserted-by":"crossref","first-page":"E558","DOI":"10.1161\/CIR.0000000000001107","article-title":"An overview of telehealth in the management of cardiovascular disease: a scientific statement from the American Heart Association","volume":"146","author":"Takahashi","year":"2022","journal-title":"Circulation"},{"key":"2025051119521147100_zwae026-B34","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/1357633X211022907","article-title":"The clinical effectiveness of telehealth: a systematic review of meta-analyses from 2010 to 2019","volume":"29","author":"Snoswell","year":"2023","journal-title":"J Telemed Telecare"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwae026\/56258645\/zwae026.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/32\/7\/596\/56258645\/zwae026.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/32\/7\/596\/56258645\/zwae026.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T23:52:24Z","timestamp":1747007544000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/32\/7\/596\/7578428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,19]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,1,19]]},"published-print":{"date-parts":[[2025,5,12]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwae026","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2024,1,19]]}}}